Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2013-001838-17-ES
EUCTR2013-001838-17-ES
Active, not recruiting
Not Applicable

PROSPECTIVE MULTICENTER CLINICAL TRIAL RANDOMIZED, DOUBLE-BLIND, PARALLEL-CONTROLLED VERSUS PLACEBO IN A POLYVALENT SUBLINGUAL BACTERIAL VACCINE (IN ORAL MUCOSA) TO THREE MONTHS AND SIX MONTHS IN WOMEN WITH RECURRENT URINARY TRACT INFECTIONS FOR THE IMMUNOMODULATORY EFFICACY EVALUATION, SAFETY AND CLINICAL IMPACT

Inmunotek, S.L.0 sitesFebruary 16, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRecurrent Urinary Tract InfectionsMedDRA version: 17.1Level: LLTClassification code 10038140Term: Recurrent urinary tract infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Recurrent Urinary Tract Infections
Sponsor
Inmunotek, S.L.
Status
Active, not recruiting
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 16, 2015
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
Inmunotek, S.L.

Eligibility Criteria

Inclusion Criteria

  • •\-Gave written informed consent.
  • •\-Aged between 18 and 75 years.
  • •\-They must be able to meet the dosing regimen.
  • •\-Individuals who have had at least 3 episodes of cystitis in the past 12 months.
  • •\-Subject that does not have responded to health and hygiene measures and/or suppressive treatments and/or postcoital prophylaxis.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 240
  • •F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • •\-Not have granted the informed written consent.
  • •\-Not included in the established age range.
  • •\-Not to offer cooperation I have serious psychiatric disorders.
  • •\-Present pathological post\-voiding residue.
  • •\-Submit moderada\-grave incontinence.
  • •\-Present genital tumors.
  • •\-Suffering from urinary tract tumors.
  • •\-Submit lithiasis.
  • •\-Present alterations in the immune system.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
Multicenter Clinical Trial for the Treatment of Dry Eye and Meibomian Gland Dysfunction whit iLUXBlepharitisC11.496.260
RBR-2wbrh3tClínica Oftalmológica Pereira Gomes
Active, not recruiting
Not Applicable
A study Protocol for patients with relapsed osteosarcomaHigh malignancy grade of osteosarcoma relapseMedDRA version: 14.1Level: PTClassification code 10031296Term: Osteosarcoma recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2012-001010-42-ITITALIAN SARCOMA GROUP
Not yet recruiting
Not Applicable
A Prospective, Multicenter, Randomized Clinical Trial to Evaluate the Safety and Effectiveness of ELIOS Compared to iStent inject W in Patients with Open-Angle Glaucoma Undergoing Cataract Surgery
NL-OMON56815ELIOS Vision Inc14
Completed
Phase 4
Multi-centre Prospective Randomized Trial Intravenous Itraconazole versus Liposomal Amphotericin B For Empirical Antifungal Therapy In Patients With Persistent fever And Neutropenia (ILEAN study)
JPRN-UMIN000005529ational Hospital Organization850
Active, not recruiting
Not Applicable
Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsissevere sepsis / septic shockMedDRA version: 14.1Level: PTClassification code 10040047Term: SepsisSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2007-004333-42-DEFriedrich-Schiller-University of Jena